The partnership, which will initially remain effective for three years, will facilitate Apollo AyurVAID and JNTBGRI to undertake joint R&D initiatives that cover silico drug
The partnership, which will initially remain effective for three years, will facilitate Apollo AyurVAID and JNTBGRI to undertake joint R&D initiatives that cover silico drug
